| [-2]proenzyme prostate specific antigen for prostate cancer detection: a national cancer institute early detection research network validation study. |
18550118 |
J Urol |
| A highly sensitive targeted mass spectrometric assay for quantification of AGR2 protein in human urine and serum. |
24251762 |
J Proteome Res |
| A multicenter study of [-2]pro-prostate specific antigen combined with prostate specific antigen and free prostate specific antigen for prostate cancer detection in the 2.0 to 10.0 ng/ml prostate specific antigen range. |
21419439 |
J Urol |
| A multiplex immunoassay of serum biomarkers for the detection of uveal melanoma. |
30867659 |
Clin Proteomics |
| A prospective, multicenter, National Cancer Institute Early Detection Research Network study of [-2]proPSA: improving prostate cancer detection and correlating with cancer aggressiveness. |
20447916 |
Cancer Epidemiol Biomarkers Prev |
| A unique proteolytic fragment of alpha1-antitrypsin is elevated in ductal fluid of breast cancer patient. |
19902353 |
Breast Cancer Res Treat |
| AISAIC: a software suite for accurate identification of significant aberrations in cancers. |
24292941 |
Bioinformatics |
| An integrated proteomic and glycoproteomic approach uncovers differences in glycosylation occupancy from benign and malignant epithelial ovarian tumors. |
28491011 |
Clin Proteomics |
| Analysis of serum protein glycosylation by a differential lectin immunosorbant assay (dLISA). |
24015777 |
Clin Proteomics |
| Analytical validation of serum proteomic profiling for diagnosis of prostate cancer: sources of sample bias. |
17981926 |
Clin Chem |
| Annexin XI is associated with cisplatin resistance and related to tumor recurrence in ovarian cancer patients. |
17982121 |
Clin Cancer Res |
| Application of traditional clinical pathology quality control techniques to molecular pathology. |
18258922 |
J Mol Diagn |
| Association Between Combined TMPRSS2:ERG and PCA3 RNA Urinary Testing and Detection of Aggressive Prostate Cancer. |
28520829 |
JAMA Oncol |
| Biomarkers in prostate cancer: what's new? |
24626128 |
Curr Opin Oncol |
| Can urinary PCA3 supplement PSA in the early detection of prostate cancer? |
25385735 |
J Clin Oncol |
| Cancer biomarker discovery and translation: proteomics and beyond. |
30556752 |
Expert Rev Proteomics |
| Cancer biomarker discovery in plasma using a tissue-targeted proteomic approach. |
17932335 |
Cancer Epidemiol Biomarkers Prev |
| Cancer proteomics: in pursuit of "true" biomarker discovery. |
16214905 |
Cancer Epidemiol Biomarkers Prev |
| Clinical utility of proPSA and "benign" PSA when percent free PSA is less than 15%. |
15596190 |
Urology |
| Combining multiple serum tumor markers improves detection of stage I epithelial ovarian cancer. |
17920110 |
Gynecol Oncol |
| Comparison of total prostate-specific antigen and derivative levels in a screening population of black, white, and Korean-American men. |
15040861 |
Clin Prostate Cancer |
| Complexed prostate-specific antigen as a staging tool for prostate cancer: a prospective study in 420 men. |
12384158 |
Urology |
| Comprehensive analysis of protein glycosylation by solid-phase extraction of N-linked glycans and glycosite-containing peptides. |
26571101 |
Nat Biotechnol |
| Detection and verification of glycosylation patterns of glycoproteins from clinical specimens using lectin microarrays and lectin-based immunosorbent assays. |
21975078 |
Anal Chem |
| Detection of prostate cancer using serum proteomics pattern in a histologically confirmed population. |
15076276 |
J Urol |
| Development of a glycoproteomic strategy to detect more aggressive prostate cancer using lectin-immunoassays for serum fucosylated PSA. |
30996714 |
Clin Proteomics |
| Enzymes and related proteins as cancer biomarkers: a proteomic approach. |
17382922 |
Clin Chim Acta |
| Evaluation of proprostate specific antigen for early detection of prostate cancer in men with a total prostate specific antigen range of 4.0 to 10.0 ng/ml. |
12913682 |
J Urol |
| Evaluation of serum protein profiling by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry for the detection of prostate cancer: I. Assessment of platform reproducibility. |
15613711 |
Clin Chem |
| Expression and clinicopathological significance of oestrogen-responsive ezrin-radixin-moesin-binding phosphoprotein 50 in breast cancer. |
17593079 |
Histopathology |
| Glycoproteomic analysis of bronchoalveolar lavage (BAL) fluid identifies tumor-associated glycoproteins from lung adenocarcinoma. |
23802180 |
J Proteome Res |
| Glycoproteomics for prostate cancer detection: changes in serum PSA glycosylation patterns. |
19035787 |
J Proteome Res |
| GPQuest: A Spectral Library Matching Algorithm for Site-Specific Assignment of Tandem Mass Spectra to Intact N-glycopeptides. |
25945896 |
Anal Chem |
| Identification of biomarkers for breast cancer in nipple aspiration and ductal lavage fluid. |
16322290 |
Clin Cancer Res |
| Identification of glycoproteins containing specific glycans using a lectin-chemical method. |
25837443 |
Anal Chem |
| Identification of Serum Biomarker Panels for the Early Detection of Pancreatic Cancer. |
30333219 |
Cancer Epidemiol Biomarkers Prev |
| Integrated analyses of proteins and their glycans in a magnetic bead-based multiplex assay format. |
23099556 |
Clin Chem |
| Integrated glycoprotein immobilization method for glycopeptide and glycan analysis of cardiac hypertrophy. |
26378618 |
Anal Chem |
| Longitudinal assessment of urinary PCA3 for predicting prostate cancer grade reclassification in favorable-risk men during active surveillance. |
28417979 |
Prostate Cancer Prostatic Dis |
| Multicenter Evaluation of the Prostate Health Index to Detect Aggressive Prostate Cancer in Biopsy Naïve Men. |
25636659 |
J Urol |
| Multiplexed Targeted Mass Spectrometry-Based Assays for the Quantification of N-Linked Glycosite-Containing Peptides in Serum. |
26451657 |
Anal Chem |
| Network biology in medicine and beyond. |
25140061 |
Circ Cardiovasc Genet |
| Predicting prostate cancer biochemical recurrence using a panel of serum proteomic biomarkers. |
19157448 |
J Urol |
| Proenzyme psa for the early detection of prostate cancer in the 2.5-4.0 ng/ml total psa range: preliminary analysis. |
12597929 |
Urology |
| Prostate Health Index improves multivariable risk prediction of aggressive prostate cancer. |
27743489 |
BJU Int |
| ProteinChips: the essential tools for proteomic biomarker discovery and future clinical diagnostics. |
16309362 |
Clin Chem Lab Med |
| Proteomic analysis of dunning prostate cancer cell lines with variable metastatic potential using SELDI-TOF. |
15264244 |
Prostate |
| Proteomic cancer biomarkers from discovery to approval: it's worth the effort. |
24646122 |
Expert Rev Proteomics |
| Quantification of fragments of human serum inter-alpha-trypsin inhibitor heavy chain 4 by a surface-enhanced laser desorption/ionization-based immunoassay. |
16574760 |
Clin Chem |
| SELDI-TOF MS whole serum proteomic profiling with IMAC surface does not reliably detect prostate cancer. |
18024530 |
Clin Chem |
| Serum fucosylated prostate-specific antigen (PSA) improves the differentiation of aggressive from non-aggressive prostate cancers. |
25553114 |
Theranostics |
| Suppression of annexin A11 in ovarian cancer: implications in chemoresistance. |
19484149 |
Neoplasia |
| The prostate health index selectively identifies clinically significant prostate cancer. |
25463993 |
J Urol |
| The road from discovery to clinical diagnostics: lessons learned from the first FDA-cleared in vitro diagnostic multivariate index assay of proteomic biomarkers. |
20962299 |
Cancer Epidemiol Biomarkers Prev |
| Tissue proteomics using chemical immobilization and mass spectrometry. |
25283129 |
Anal Biochem |
| Tyramide signal amplification for antibody-overlay lectin microarray: a strategy to improve the sensitivity of targeted glycan profiling. |
21133419 |
J Proteome Res |
| Updating risk prediction tools: a case study in prostate cancer. |
22095849 |
Biom J |
| Validation of a multiplex immunoassay for serum angiogenic factors as biomarkers for aggressive prostate cancer. |
22722017 |
Clin Chim Acta |
| Validation of a novel model for the early detection of hepatocellular carcinoma. |
30675135 |
Clin Proteomics |
